Literature DB >> 27753163

Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state.

H-J Kim1, S-I Oh2, M de Leon3, X Wang4, K-W Oh1, J-S Park1, A Deshpande3, M Buj3, S H Kim1.   

Abstract

BACKGROUND AND
PURPOSE: Amyotrophic lateral sclerosis (ALS), a motor neuron disease, is associated with various cortical symptoms including mild cognitive decline with behavior changes, suggesting the involvement of extra-motor areas in ALS. Our aim was to investigate the specific patterns of brain atrophy in sporadic, impaired ALS patients without commonly known genetic mutations using voxel-based morphometry.
MATERIALS AND METHODS: Forty-seven patients with sporadic ALS and 28 age-matched healthy controls were recruited. ALS participants were divided into three groups according to comprehensive neuropsychological testing: pure (ALS-pure), cognitive impairment (ALSci) and behavioral impairment (ALSbi). Quantitative comparison of brain atrophy patterns was performed amongst these three groups using voxel-based analysis. All analyses were adjusted for total intracranial volume, age, sex, disease duration and functional disability score.
RESULTS: The ALSci group exhibited decreased volume in the left cerebellum, fusiform gyrus, optic radiations and corticospinal tracts compared to healthy controls. ALSci patient imaging showed decreased brain volume in the bilateral cerebellum, right putamen gray matter and bilateral superior longitudinal fasciculi white matter compared to pure ALS patients (P < 0.001 uncorrected, corrected for the entire volume). Compared to healthy controls, ALS-pure and ALSbi groups did not show any significant volume changes in gray and white matter.
CONCLUSIONS: These findings also support the hypothesis that ALS pathogenesis has a dual focality of onset (cortex and anterior horn) with contiguous spread outwards. Additionally, neuropsychological features may be an important predictor of progression and survival rates in ALS.
© 2016 EAN.

Entities:  

Keywords:  amyotrophic lateral sclerosis; atrophy; cognitive impairment; voxel-based morphometry

Mesh:

Year:  2016        PMID: 27753163      PMCID: PMC5436047          DOI: 10.1111/ene.13163

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  43 in total

1.  The diagnostic utility of FLAIR imaging in clinically verified amyotrophic lateral sclerosis.

Authors:  Lijuan Zhang; Aziz M Ulug; Robert D Zimmerman; Michael T Lin; Michael Rubin; M Flint Beal
Journal:  J Magn Reson Imaging       Date:  2003-05       Impact factor: 4.813

Review 2.  The involvement of the cerebellum in amyotrophic lateral sclerosis.

Authors:  Tino Prell; Julian Grosskreutz
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-07-29       Impact factor: 4.092

Review 3.  Clinical phenomenology and neuroimaging correlates in ALS-FTD.

Authors:  Catherine Lomen-Hoerth
Journal:  J Mol Neurosci       Date:  2011-10-05       Impact factor: 3.444

4.  Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis.

Authors:  D M Mezzapesa; A Ceccarelli; F Dicuonzo; A Carella; M F De Caro; M Lopez; V Samarelli; P Livrea; I L Simone
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

5.  Diagnostic accuracy using diffusion tensor imaging in the diagnosis of ALS: a meta-analysis.

Authors:  Bradley R Foerster; Ben A Dwamena; Myria Petrou; Ruth C Carlos; Brian C Callaghan; Martin G Pomper
Journal:  Acad Radiol       Date:  2012-06-28       Impact factor: 3.173

6.  Do preprocessing algorithms and statistical models influence voxel-based morphometry (VBM) results in amyotrophic lateral sclerosis patients? A systematic comparison of popular VBM analytical methods.

Authors:  Venkateswaran Rajagopalan; Guang H Yue; Erik P Pioro
Journal:  J Magn Reson Imaging       Date:  2013-10-31       Impact factor: 4.813

7.  Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis.

Authors:  Michael J Strong; Gloria M Grace; Morris Freedman; Cathy Lomen-Hoerth; Susan Woolley; Laura H Goldstein; Jennifer Murphy; Christen Shoesmith; Jeffery Rosenfeld; P Nigel Leigh; Lucie Bruijn; Paul Ince; Denise Figlewicz
Journal:  Amyotroph Lateral Scler       Date:  2009-06

8.  VBM lesion detection depends on the normalization template: a study using simulated atrophy.

Authors:  Shan Shen; Andre J Szameitat; Annette Sterr
Journal:  Magn Reson Imaging       Date:  2007-04-30       Impact factor: 2.546

Review 9.  What does imaging reveal about the pathology of amyotrophic lateral sclerosis?

Authors:  Martin R Turner; Esther Verstraete
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

10.  Cerebellar integrity in the amyotrophic lateral sclerosis-frontotemporal dementia continuum.

Authors:  Rachel H Tan; Emma Devenney; Carol Dobson-Stone; John B Kwok; John R Hodges; Matthew C Kiernan; Glenda M Halliday; Michael Hornberger
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

View more
  2 in total

Review 1.  Cerebellar pathology in motor neuron disease: neuroplasticity and neurodegeneration.

Authors:  Rangariroyashe H Chipika; Grainne Mulkerrin; Pierre-François Pradat; Aizuri Murad; Fabrice Ango; Cédric Raoul; Peter Bede
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

2.  Voxel-based mapping of grey matter volume and glucose metabolism profiles in amyotrophic lateral sclerosis.

Authors:  M-S Buhour; F Doidy; A Mondou; A Pélerin; L Carluer; F Eustache; F Viader; B Desgranges
Journal:  EJNMMI Res       Date:  2017-03-06       Impact factor: 3.138

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.